期刊
ONCOGENE
卷 30, 期 11, 页码 1261-1271出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.530
关键词
cancer stem cell; prostate cancer; mouse models; cell of origin; tumor-initiating cell
资金
- NIH
- DOD
The cancer stem cell (CSC) model proposes that cells within a tumor are organized in a hierarchical lineage relationship and display different tumorigenic potential, suggesting that effective therapeutics should target rare CSCs that sustain tumor malignancy. Here we review the current status of studies to identify CSCs in human prostate cancer as well as mouse models, with an emphasis on discussing different functional assays and their advantages and limitations. We also describe current controversies regarding the identification of prostate epithelial stem cells and cell types of origin for prostate cancer, and present potential resolutions of these issues. Although definitive evidence for the existence of CSCs in prostate cancer is still lacking, future directions pursuing the identification of tumor-initiating stem cells in the mouse may provide important advances in evaluating the CSC model for prostate cancer. Oncogene (2011) 30, 1261-1271; doi: 10.1038/onc.2010.530; published online 29 November 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据